Chemical structure of erythromycin and hepatotoxicity.
D001706:Biopsy; D055598:Chemical Phenomena; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002621:Chemistry; D003165:Complement System Proteins / Q000032:analysis; D003429:Cross Reactions; D004917:Erythromycin / Q000097:blood / Q000627:therapeutic use / Q000633:toxicity*; D006505:Hepatitis / Q000517:prevention & control; D006801:Humans; D007109:Immunity; D007111:Immunity, Cellular; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D008099:Liver / Q000187:drug effects* / Q000473:pathology; D008213:Lymphocyte Activation; D011422:Propionates / Q000633:toxicity; D012214:Rheumatic Heart Disease / Q000276:immunology; D012967:Sodium Dodecyl Sulfate / Q000633:toxicity; D013229:Stearic Acids / Q000633:toxicity; D013386:Succinates / Q000633:toxicity; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D011422:Propionates; D013229:Stearic Acids; D013386:Succinates; D014316:Tritium; D012967:Sodium Dodecyl Sulfate; D004917:Erythromycin; D003165:Complement System Proteins; D013936:Thymidine